Pat on the back for UK life science decision-makers
This article was originally published in Scrip
Rare are the times when government and industry see eye to eye, and the proverbial “hens’ teeth” are as common as public sector decision-makers basking in the warm glow of public praise.
You may also be interested in...
While personal data security must be balanced againt the right to health, winning “trust” is the key to taking AI adoption to the next stage, says a new report focused on the European market.
The latest guidance from the UK devices regulator fills in some of the information gaps for companies addressing the Northern Ireland and EU27 markets after this year, seen through the lens of Brexit.
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.